8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prostate Cancer Phenotype Influences Bone Mineralization at Metastasis: A Study Using an In Vitro Prostate Cancer Metastasis Testbed

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          In this study, two types of prostate cancer cell lines, highly metastatic PC‐3 and low metastatic MDA PCa 2b (PCa) were cultured on bone mimetic scaffolds to recapitulate metastasis to bone. A unique in vitro 3D tumor model that uses a sequential culture (SC) of human mesenchymal stem cells followed by seeding with cancer cells after bone formation was initiated to study the phenotype‐specific interaction between prostate cancer cells and bone microenvironment. The PCa cells were observed to be less prolific and less metastatic, and to form multicellular tumoroids in the bone microenvironment, whereas PC‐3 cells were more prolific and were highly metastatic, and did not form multicellular tumoroids in the bone microenvironment. The metastatic process exhibited by these two prostate cancer cell lines showed a significant and different effect on bone mineralization and extracellular matrix formation. Excessive bone formation in the presence of PC‐3 and significant osteolysis in the presence of PCa were observed, which was also indicated by osteocalcin and MMP‐9 expression as measured by ELISA and qRT‐PCR. The field emission scanning electron microscopy images revealed that the structure of mineralized collagen in the presence of PC‐3 is different than the one observed in healthy bone. All experimental results indicated that both osteolytic and osteoblastic bone lesions can be recapitulated in our tumor testbed model and that different cancer phenotypes have a very different influence on bone at metastasis. The 3D in vitro model presented in this study provides an improved, reproducible, and controllable system that is a useful tool to elucidate osteotropism of prostate cancer cells. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

          The prognosis of prostate cancer is mainly determined by the presence or absence of metastases. Nevertheless, the metastatic pathways in prostate cancer are not entirely understood. Among 19,316 routine autopsies performed from 1967 to 1995 on men older than 40 years of age, the reports from those 1,589 (8.2%) with prostate cancer were analyzed. Hematogeneous metastases were present in 35% of 1,589 patients with prostate cancer, with most frequent involvement being bone (90%), lung (46%), liver (25%), pleura (21%), and adrenals (13%). Several lines of evidence suggested the existence of a backward metastatic pathway through veins from the prostate to the spine in addition to classical hematogeneous tumor spread via the vena cava. First, there was an inverse relationship between spine and lung metastases, suggesting that metastasis to the spine is independent of lung metastasis. Second, the maximum frequency of spine involvement occurred in smaller tumors (4 to 6 cm) as compared with the maximum spread to lung (6 to 8 cm) and liver (>8 cm), suggesting that spine metastases precede lung and liver metastases in many prostate cancers. Third, there was a gradual decrease in spine involvement from the lumbar to the cervical level (97% v 38%), which is consistent with a subsequent upward metastatic spread along spinal veins after initial lumbar metastasis. The results of this study show that bone, lung, and liver are the most frequent sites of distant prostate cancer metastases. Besides the cava-type of metastasis through lung passage, there are strong arguments for the existence and clinical significance of a backward venous spread to the spine, which is likely to occur early in the metastatic process.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2

            Runx2 is essential for osteoblast differentiation and chondrocyte maturation. During osteoblast differentiation, Runx2 is weakly expressed in uncommitted mesenchymal cells, and its expression is upregulated in preosteoblasts, reaches the maximal level in immature osteoblasts, and is down-regulated in mature osteoblasts. Runx2 enhances the proliferation of osteoblast progenitors by directly regulating Fgfr2 and Fgfr3. Runx2 enhances the proliferation of suture mesenchymal cells and induces their commitment into osteoblast lineage cells through the direct regulation of hedgehog (Ihh, Gli1, and Ptch1), Fgf (Fgfr2 and Fgfr3), Wnt (Tcf7, Wnt10b, and Wnt1), and Pthlh (Pthr1) signaling pathway genes, and Dlx5. Runx2 heterozygous mutation causes open fontanelle and sutures because more than half of the Runx2 gene dosage is required for the induction of these genes in suture mesenchymal cells. Runx2 regulates the proliferation of osteoblast progenitors and their differentiation into osteoblasts via reciprocal regulation with hedgehog, Fgf, Wnt, and Pthlh signaling molecules, and transcription factors, including Dlx5 and Sp7. Runx2 induces the expression of major bone matrix protein genes, including Col1a1, Spp1, Ibsp, Bglap2, and Fn1, in vitro. However, the functions of Runx2 in differentiated osteoblasts in the expression of these genes in vivo require further investigation.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

              O V BATSON (1940)
                Bookmark

                Author and article information

                Contributors
                kalpana.katti@ndsu.edu
                Journal
                JBMR Plus
                JBMR Plus
                10.1002/(ISSN)2473-4039
                JBM4
                JBMR Plus
                John Wiley & Sons, Inc. (Hoboken, USA )
                2473-4039
                30 December 2019
                February 2020
                : 4
                : 2 ( doiID: 10.1002/jbm4.v4.2 )
                : e10256
                Affiliations
                [ 1 ] Center for Engineered Cancer Testbeds North Dakota State University Fargo ND USA
                [ 2 ] Department of Civil and Environmental Engineering North Dakota State University Fargo ND USA
                [ 3 ] Department of Urology, Saint Elizabeth's Medical Center Tufts University Boston MA USA
                [ 4 ] Department of Chemistry and Chemical Biology Northeastern University Boston MA USA
                [ 5 ] Department of Radiology Cellular Pathway Imaging Laboratory (CPIL), Stanford University School of Medicine Palo Alto CA USA
                [ 6 ] Center for Life Sciences Boston Children's Hospital, Harvard Medical School, Boston Massachusetts USA
                [ 7 ] Scintillon Institute San Diego USA
                Author notes
                [*] [* ]Address correspondence to: Kalpana S Katti, Center for Engineered Cancer Testbeds, North Dakota State University, Fargo, ND. E‐mail: kalpana.katti@ 123456ndsu.edu
                Author information
                https://orcid.org/0000-0003-3643-2385
                https://orcid.org/0000-0001-9866-2683
                https://orcid.org/0000-0002-1404-4018
                Article
                JBM410256
                10.1002/jbm4.10256
                7017885
                32083238
                4fda5938-c583-413b-b23c-7917765dfafc
                © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 19 August 2019
                : 01 November 2019
                : 13 November 2019
                Page count
                Figures: 7, Tables: 1, Pages: 14, Words: 11533
                Funding
                Funded by: Center for Engineered Cancer Testbeds
                Funded by: North Dakota , open-funder-registry 10.13039/100008109;
                Funded by: National Science Foundation , open-funder-registry 10.13039/100000001;
                Funded by: NDSU , open-funder-registry 10.13039/100006351;
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                February 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.5 mode:remove_FC converted:13.02.2020

                prostate cancer; collagen,bone matrixmatrix mineralization,bone matrixtumor‐induced bone disease,cancer,osteoblasts,bone cells

                Comments

                Comment on this article